Geode Capital Management LLC Sells 296 Shares of John Wiley & Sons, Inc. (NYSE:WLY)

Geode Capital Management LLC trimmed its position in John Wiley & Sons, Inc. (NYSE:WLY) by 0.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 881,708 shares of the company’s stock after selling 296 shares during the period. Geode Capital Management LLC’s holdings in John Wiley & Sons were worth $42,552,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Victory Capital Management Inc. increased its holdings in shares of John Wiley & Sons by 113.6% during the third quarter. Victory Capital Management Inc. now owns 35,762 shares of the company’s stock valued at $1,726,000 after acquiring an additional 19,017 shares in the last quarter. Eagle Asset Management Inc. increased its stake in John Wiley & Sons by 40.1% during the 3rd quarter. Eagle Asset Management Inc. now owns 407,997 shares of the company’s stock valued at $21,273,000 after purchasing an additional 116,772 shares in the last quarter. D.A. Davidson & CO. acquired a new position in John Wiley & Sons during the third quarter worth $2,134,000. Acadian Asset Management LLC bought a new position in shares of John Wiley & Sons in the second quarter valued at $1,418,000. Finally, Arjuna Capital grew its holdings in shares of John Wiley & Sons by 213.3% during the second quarter. Arjuna Capital now owns 54,378 shares of the company’s stock valued at $2,213,000 after buying an additional 37,019 shares during the last quarter. 73.94% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at John Wiley & Sons

In other news, EVP Danielle Mcmahan sold 2,318 shares of the business’s stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total value of $114,532.38. Following the transaction, the executive vice president now owns 8,978 shares in the company, valued at $443,602.98. The trade was a 20.52 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.62% of the company’s stock.

John Wiley & Sons Trading Up 0.8 %

NYSE:WLY opened at $44.71 on Tuesday. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.66 and a quick ratio of 0.61. John Wiley & Sons, Inc. has a one year low of $30.45 and a one year high of $53.96. The company has a market cap of $2.42 billion, a PE ratio of -49.13 and a beta of 0.85. The firm has a 50-day moving average of $49.50 and a 200-day moving average of $46.67.

John Wiley & Sons (NYSE:WLY) last issued its quarterly earnings data on Thursday, December 5th. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.09. The firm had revenue of $426.60 million during the quarter, compared to analyst estimates of $420.00 million. John Wiley & Sons had a positive return on equity of 24.14% and a negative net margin of 2.82%. The firm’s quarterly revenue was down 13.4% compared to the same quarter last year. As a group, equities research analysts expect that John Wiley & Sons, Inc. will post 3.42 EPS for the current fiscal year.

John Wiley & Sons Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, December 26th will be given a $0.3525 dividend. This is a positive change from John Wiley & Sons’s previous quarterly dividend of $0.35. This represents a $1.41 dividend on an annualized basis and a yield of 3.15%. The ex-dividend date of this dividend is Thursday, December 26th. John Wiley & Sons’s dividend payout ratio is presently -154.95%.

John Wiley & Sons Profile

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.